This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The
Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist
✍ Scribed by Rosalía Tenorio-Martínez; María del Carmen Lara-Muñoz; María Elena Medina-Mora
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 187 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1433-9285
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Symptomatic anxiety has prognostic significance in major depression. In theory, the Hospital Anxiety and Depression Scale (HADS) should be a useful instrument for measuring the severity of symptomatic anxiety in late‐life depression. However, the dimensional structure of t
## Abstract The Hospital Anxiety and Depression Scale (HADS) is a widely used screening instrument for depression and anxiety in medically compromised patients. The purpose of this study was to examine the differential item functioning (DIF) of the anxiety subscale of the HADA (HADS‐A). A research